We are live on
!
Find out more
AFM
Anson Funds Management Portfolio holdings
AUM
$1.68B
1-Year Est. Return
373.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.89%
1 Year Est. Return
+373.57%
3 Year Est. Return
+2,009.68%
5 Year Est. Return
+1,118.82%
10 Year Est. Return
+17,700.84%
AUM
$1B
AUM Growth
+$163M
(+19%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
45.25%
Holding
220
New
64
Increased
24
Reduced
33
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIVE9
FIVN
|
+$53.3M |
| 2 |
Occidental Petroleum
OXY
|
+$42.5M |
| 3 |
Cenovus Energy
CVE
|
+$22.7M |
| 4 |
Albertsons Companies
ACI
|
+$21.1M |
| 5 |
HES
Hess
HES
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gildan
GIL
|
+$84.1M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$19.7M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$15M |
| 4 |
Summit Therapeutics
SMMT
|
+$7.35M |
| 5 |
Vivid Seats
SEAT
|
+$6.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.31% |
| 2 | Technology | 14.3% |
| 3 | Energy | 12.26% |
| 4 | Communication Services | 11.71% |
| 5 | Real Estate | 4.34% |
Similar funds
MCM
TP
KFGK
BCLSI
BCAM
CWG
PWMAG
CC
Anson Funds Management's Q3 2024 Portfolio in Review
As of Q3 2024, Anson Funds Management held 220 positions worth $1B, up 19% from $839M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Anson Funds Management's Q3 2024 filing shows 64 new, 24 increased, 33 reduced and 63 closed positions. Its largest new stake was FIVE9: 1,476,744 shares worth $42.4M. The largest sale was Gildan, an estimated $84.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 40% a quarter earlier, followed by Technology and Energy.
- Anson Funds Management's largest Q3 2024 buy was FIVE9: 1,476,744 shares worth $42.4M.
- Anson Funds Management added most to Occidental Petroleum in Q3 2024, an estimated $42.5M increase.
- Anson Funds Management's biggest Q3 2024 reduction was Gildan, cutting an estimated $84.1M.
- Anson Funds Management fully exited Summit Therapeutics in Q3 2024, selling an estimated $7.35M.
- Anson Funds Management's ten largest holdings make up 45% of its $1B portfolio in Q3 2024.
- Anson Funds Management opened 64 new positions and closed 63 in Q3 2024.
- Anson Funds Management's portfolio value rose 19% quarter-over-quarter to $1B.
Based on Anson Funds Management's 13F filing for Q3 2024, filed 14 Nov 2024.